Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview Of Cell Separation And Isolation01:20

Overview Of Cell Separation And Isolation

5.9K
Cell separation was first achieved in 1964 by S. H. Seal, who separated large tumor cells from the smaller blood cells using filtration. Two years later, Pohl and Hawk performed experiments on how cells respond differently to a nonuniform electric field based on the cell type. Such observations were the inception of cell separation methods, which allow isolating a single cell type from a heterogeneous sample.
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasensitive Profiling of Extracellular Vesicles by a Microbead- and Aptamer-Enhanced Thermophoretic Assay for Monitoring Therapeutic Responses.

Analytical chemistry·2025
Same author

Multivalent Metal-Nucleotide Nanoagonists Amplify Innate Immune Activation for Cancer Metalloimmunotherapy.

Nano letters·2025
Same author

Extracellular Vesicles for Clinical Diagnostics: From Bulk Measurements to Single-Vesicle Analysis.

ACS nano·2025
Same author

Mitoxantrone-Encapsulated ZIF-8 Enhances Chemo-Immunotherapy via Amplified Immunogenic Cell Death.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Spherical DNA Nanomotors Enable Ultrasensitive Detection of Active Enzymes in Extracellular Vesicles for Cancer Diagnosis.

Angewandte Chemie (International ed. in English)·2024
Same author

Thermophoretic glycan profiling of extracellular vesicles for triple-negative breast cancer management.

Nature communications·2024

Related Experiment Video

Updated: Aug 12, 2025

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.3K

Poly(ethylene oxide) Concentration Gradient-Based Microfluidic Isolation of Circulating Tumor Cells.

Yangchang Cheng1,2, Shaohua Zhang3, Lili Qin3

  • 1Beijing Engineering Research Center for BioNanotechnology, CAS Key Laboratory of Standardization and Measurement for Nanotechnology, National Center for Nanoscience and Technology, Beijing 100190, China.

Analytical Chemistry
|February 1, 2023
PubMed
Summary

This study introduces a microfluidic device using a poly(ethylene oxide) concentration gradient to isolate rare circulating tumor cells (CTCs) from blood. This label-free method rapidly enriches CTCs for improved cancer detection.

More Related Videos

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
07:32

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

Published on: June 15, 2012

26.8K
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

8.7K

Related Experiment Videos

Last Updated: Aug 12, 2025

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.3K
Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
07:32

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

Published on: June 15, 2012

26.8K
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

8.7K

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Microfluidics

Background:

  • Circulating tumor cells (CTCs) are vital biomarkers for non-invasive cancer diagnosis and management.
  • The rarity and heterogeneity of CTCs pose significant challenges for their isolation and detection in clinical settings.

Purpose of the Study:

  • To develop a rapid, label-free, and highly efficient microfluidic method for isolating CTCs directly from whole blood.
  • To utilize a poly(ethylene oxide) (PEO) concentration gradient for size-based CTC separation.

Main Methods:

  • A microfluidic device was engineered to create stable PEO concentration gradients.
  • Co-injection of blood sample and PEO solutions generated elastic and inertial lift forces for cell separation.
  • Size-based separation of CTCs from blood cells was achieved by exploiting distinct migration patterns.

Main Results:

  • The microfluidic device processed 1 mL of blood in 30 minutes with over 90% separation efficiency.
  • An enrichment ratio exceeding 700 for tumor cells was achieved.
  • Discrimination between breast cancer patients and healthy donors with 84.2% accuracy was demonstrated using isolated CTCs.

Conclusions:

  • The PEO concentration gradient microfluidic method offers a powerful tool for label-free CTC isolation.
  • This technique demonstrates significant potential for various clinical applications in cancer diagnostics and monitoring.